Abstract:Objective To investigate the influence of dexmedetomidine on the neurotoxicity induced by sevoflurane in rats and the possible mechanisms. Methods Sixty seven-day-old male and female Sprague-Dawley rats weighing 15-20 g were randomly divided into normal saline group, dexmedetomidine group, sevoflurane group and dexmedetomidine plus sevoflurane group. The rats in the normal saline group and sevoflurane group were intraperitoneally given 10 μL normal saline and placed in a sealed box to inhale the mixed gas (30% O2+70% N2). The rats in the dexmedetomidine group and dexmedetomidine plus sevoflurane group were given dexmedetomidine (25 μg/kg, diluted with normal saline to 10 μL) intraperitoneally and placed in another sealed box to inhale the mixed gas containing 2% sevoflurane for 4 h. After 4 hours of disposition, 6 rats in each group were sacrificed to detect the expression of cleaved caspase-3 and p-p38 mitogen activated protein kinase (MAPK) in hippocampus by Western blotting. The rest rats were fed for 42 d, and the cognitive function was tested by Morris water maze. Results Compared with the normal saline group (0.069 4±0.090 0), the expression of cleaved caspase-3 in the sevoflurane group (0.137 3±0.200 0) was significantly increased (P<0.01). Compared with the sevoflurane group, the expression of cleaved caspase-3 in the dexmedetomidine plus sevoflurane group (0.095 8±0.130 0) was significantly decreased (P<0.05). Compared with the normal saline group (0.024 2±0.160 0), the expression of p-p38MAPK in the sevoflurane group (0.031 9±0.210 0) was significantly increased (P<0.05). Compared with the sevoflurane group, the expression of p-p38MAPK in the dexmedetomidine plus sevoflurane group (0.021 0±0.140 0) was significantly decreased (P<0.01). On day 45 and 46 of the experiment, the escape latency of the sevoflurane group was significantly prolonged compared with the normal saline group (both P<0.05), and the latency of the dexmedetomidine plus sevoflurane group was significantly shortened compared with the sevoflurane group (both P<0.05). Compared with the sevoflurane group (1.33±0.46), the frequencies of crossing the target platform in the normal saline group (3.44±0.51) and the dexmedetomidine plus sevoflurane group (1.89±0.86) were significantly increased (P<0.01 or 0.05). Conclusion Dexmedetomidine can decrease the neurotoxicity induced by sevoflurane during the development stage in rats, and p38MAPK may be involved in its mechanisms.

Effects of Dexmedetomidine on Isoflurane-Induced Neuroapoptosis and Expression of CRMP2 in Neonatal Rat Hippocampus

Effects of dexmedetomidine on isoflurane-induced apoptosis of hippocampal nerve cells in neonatal Rats

Dexmedetomidine reduced isoflurane-induced neuroapoptosis by inhibiting activation of p38 and JNK proteins in hippocampus of neonatal rats

Dexmedetomidine Reduces Isoflurane-Induced Neuroapoptosis Partly by Preserving PI3K/Akt Pathway in the Hippocampus of Neonatal Rats.

Both JNK and P38 MAPK Pathways Participate in the Protection by Dexmedetomidine Against Isoflurane-Induced Neuroapoptosis in the Hippocampus of Neonatal Rats

Dexmedetomidine Attenuates Repeated Propofol Exposure-Induced Hippocampal Apoptosis, PI3K/Akt/Gsk-3β Signaling Disruption, and Juvenile Cognitive Deficits in Neonatal Rats

HIF-α/PKM2 and PI3K-AKT Pathways Involved in the Protection by Dexmedetomidine Against Isoflurane or Bupivacaine-Induced Apoptosis in Hippocampal Neuronal HT22 Cells.

Dexmedetomidine Ameliorates the Neurotoxicity of Sevoflurane on the Immature Brain Through the BMP/SMAD Signaling Pathway

Mechanisms of Propofol Attenuation of Ketamine-Induced Neonatal Brain Injury

Both GSK-3β/CRMP2 and CDK5/CRMP2 Pathways Participate in the Protection of Dexmedetomidine Against Propofol-Induced Learning and Memory Impairment in Neonatal Rats.

Influence of dexmedetomidine on sevoflurane-induced neurotoxicity in development-stage rats

Dexmedetomidine Attenuates Isoflurane-Induced Cognitive Impairment Through Antioxidant, Anti-Inflammatory and Anti-Apoptosis in Aging Rat.

Dexmedetomidine Combined with Low-Dose Propofol Declines Learning and Memory Impairment and Neural Cell Injury in Developing Rats

Effect of Dexmedetomidine on Expression of NR1 Subunit-Containing NMDA Receptors and GluR2 Subunit-Containing AMPA Receptors During Hypoxic Injury to Rat Hippocampal Neurons

Dexmedetomidine Protects Cortical Neurons from Propofol-Induced Apoptosis Via Activation of Akt-IKK-NF-κB Signaling Pathway by Α2a-Adrenoceptor.

Effects of Dexmedetomidine on Global Cerebral Ischemia-Reperfusion Injury in Rats

Dexmedetomidine Attenuates Neurotoxicity in Developing Rats Induced by Sevoflurane through Upregulating BDNF-TrkB-CREB and Downregulating ProBDNF-P75NRT-RhoA Signaling Pathway

Dexmedetomidine Improves Propofol-Induced Neuronal Injury in Rat Hippocampus with the Involvement of Mir-34A and the PI3K/Akt Signaling Pathway

Dexmedetomidine post-conditioning attenuates cerebral ischemia following asphyxia cardiac arrest through down-regulation of apoptosis and neuroinflammation in rats

Effect of dexmedetomidine on Src-mediated NR2A tyrosine phosphorylation in hippocampal neurons subjected to hypoxia-reoxygenation in mice

Dexmedetomidine Attenuates Sevoflurane‑induced Neurocognitive Impairment Through Α2‑adrenoceptors